Our results suggest the combination of CD25, TGF-β and PD-1 effectively inhibited tumor formation and progression via depleting tumor infiltrating FoxP3+ Tregs and enhancing anti-tumor immune response on the basis of IIR. This evidence concerns the gene TGFB1 and neoplasm.